Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 231

1.

Predicting Poorly Differentiated Hepatocellular Carcinoma that Meets the Milan Criteria.

Koga Y, Beppu T, Miyata T, Kitano Y, Tsuji A, Nakagawa S, Arima K, Kuramoto K, Okabe H, Imai K, Hayashi H, Nitta H, Yamashita YI, Chikamoto A, Ishiko T, Baba H.

Anticancer Res. 2018 Jul;38(7):4093-4099. doi: 10.21873/anticanres.12699.

PMID:
29970535
2.

Multimodal radiofrequency ablation versus laparoscopic hepatic resection for the treatment of primary hepatocellular carcinoma within Milan criteria in severely cirrhotic patients: long-term favorable outcomes over 10 years.

Yamashita YI, Imai K, Kaida T, Yamao T, Tsukamoto M, Nakagawa S, Okabe H, Chikamoto A, Ishiko T, Yoshizumi T, Ikeda T, Maehara Y, Baba H.

Surg Endosc. 2018 Jun 5. doi: 10.1007/s00464-018-6264-3. [Epub ahead of print]

PMID:
29872945
3.

Microvascular invasion of single small hepatocellular carcinoma ≤3 cm: Predictors and optimal treatments.

Yamashita YI, Imai K, Yusa T, Nakao Y, Kitano Y, Nakagawa S, Okabe H, Chikamoto A, Ishiko T, Yoshizumi T, Aishima S, Maehara Y, Baba H.

Ann Gastroenterol Surg. 2018 Jan 8;2(3):197-203. doi: 10.1002/ags3.12057. eCollection 2018 May.

4.

HtrA1 Is Specifically Up-Regulated in Active Keloid Lesions and Stimulates Keloid Development.

Yamawaki S, Naitoh M, Kubota H, Aya R, Katayama Y, Ishiko T, Tamura T, Yoshikawa K, Enoshiri T, Ikeda M, Suzuki S.

Int J Mol Sci. 2018 Apr 24;19(5). pii: E1275. doi: 10.3390/ijms19051275.

5.

Microvascular Invasion in Small-sized Hepatocellular Carcinoma: Significance for Outcomes Following Hepatectomy and Radiofrequency Ablation.

Imai K, Yamashita YI, Yusa T, Nakao Y, Itoyama R, Nakagawa S, Okabe H, Chikamoto A, Ishiko T, Baba H.

Anticancer Res. 2018 Feb;38(2):1053-1060.

PMID:
29374740
6.

Long-term Favorable Outcomes of Radiofrequency Ablation for Hepatocellular Carcinoma as an Initial Treatment: A Single-center Experience Over a 10-Year Period.

Tsukamoto M, Yamashita YI, Imai K, Umezaki N, Yamao T, Kaida T, Mima K, Nakagawa S, Hashimoto D, Chikamoto A, Ishiko T, Baba H.

Anticancer Res. 2018 Feb;38(2):1047-1052.

PMID:
29374739
7.

Predictors of Cure of Intrahepatic Cholangiocarcinoma After Hepatic Resection.

Tsukamoto M, Yamashita YI, Imai K, Umezaki N, Yamao T, Okabe H, Nakagawa S, Hashimoto D, Chikamoto A, Ishiko T, Yoshizumi T, Maehara Y, Baba H.

Anticancer Res. 2017 Dec;37(12):6971-6975.

PMID:
29187482
8.

Tumour-infiltrating inflammatory and immune cells in patients with extrahepatic cholangiocarcinoma.

Kitano Y, Okabe H, Yamashita YI, Nakagawa S, Saito Y, Umezaki N, Tsukamoto M, Yamao T, Yamamura K, Arima K, Kaida T, Miyata T, Mima K, Imai K, Hashimoto D, Komohara Y, Chikamoto A, Ishiko T, Baba H.

Br J Cancer. 2018 Jan;118(2):171-180. doi: 10.1038/bjc.2017.401. Epub 2017 Nov 9.

PMID:
29123259
9.

The role of intestinal bacteria in the development and progression of gastrointestinal tract neoplasms.

Mima K, Ogino S, Nakagawa S, Sawayama H, Kinoshita K, Krashima R, Ishimoto T, Imai K, Iwatsuki M, Hashimoto D, Baba Y, Sakamoto Y, Yamashita YI, Yoshida N, Chikamoto A, Ishiko T, Baba H.

Surg Oncol. 2017 Dec;26(4):368-376. doi: 10.1016/j.suronc.2017.07.011. Epub 2017 Jul 21. Review.

PMID:
29113654
10.

Impact of surgical treatment after sorafenib therapy for advanced hepatocellular carcinoma.

Takeyama H, Beppu T, Higashi T, Kaida T, Arima K, Taki K, Imai K, Nitta H, Hayashi H, Nakagawa S, Okabe H, Hashimoto D, Chikamoto A, Ishiko T, Tanaka M, Sasaki Y, Baba H.

Surg Today. 2018 Apr;48(4):431-438. doi: 10.1007/s00595-017-1603-x. Epub 2017 Nov 7.

PMID:
29110089
11.

Surgical treatment strategy for hepatocellular carcinoma in patients with impaired liver function: hepatic resection or radiofrequency ablation?

Yamao T, Imai K, Yamashita YI, Kaida T, Nakagawa S, Mima K, Hashimoto D, Chikamoto A, Ishiko T, Baba H.

HPB (Oxford). 2018 Mar;20(3):244-250. doi: 10.1016/j.hpb.2017.08.031. Epub 2017 Oct 5.

PMID:
28988913
12.

Clinical significance of half-lives of tumor markers α-fetoprotein and des-γ-carboxy prothrombin after hepatectomy for hepatocellular carcinoma.

Tsukamoto M, Nitta H, Imai K, Higashi T, Nakagawa S, Okabe H, Arima K, Kaida T, Taki K, Hashimoto D, Chikamoto A, Ishiko T, Beppu T, Baba H.

Hepatol Res. 2018 Feb;48(3):E183-E193. doi: 10.1111/hepr.12942. Epub 2017 Sep 8.

PMID:
28796412
13.

Survival impact of lymphocyte infiltration into the tumor of hepatocellular carcinoma in hepatitis B virus-positive or non-B non-C patients who underwent curative resection.

Nakagawa S, Umezaki N, Yamao T, Kaida T, Okabe H, Mima K, Imai K, Hashimoto D, Yamashita YI, Ishiko T, Chikamoto A, Baba H.

Hepatol Res. 2018 Feb;48(3):E126-E132. doi: 10.1111/hepr.12936. Epub 2017 Aug 10.

PMID:
28696046
14.

The Number of Positive Tumor Marker Status Is Beneficial for the Selection of Therapeutic Modalities in Patients with Hepatocellular Carcinoma.

Beppu T, Nakagawa S, Nitta H, Okabe H, Kaida T, Imai K, Hayashi H, Koga Y, Kuramoto K, Hashimoto D, Yamashita YI, Chikamoto A, Ishiko T, Baba H.

J Clin Transl Hepatol. 2017 Jun 28;5(2):165-168. doi: 10.14218/JCTH.2016.00055. Epub 2017 May 10. Review.

15.

Clinical Benefits of Lymph Node Dissection in Intrahepatic Cholangiocarcinoma: A Retrospective Single-institution Study.

Miyata T, Yamashita YI, Yamao T, Umezaki N, Tsukamoto M, Kitano Y, Yamamura K, Arima K, Kaida T, Nakagawa S, Imai K, Hashimoto D, Chikamoto A, Ishiko T, Baba H.

Anticancer Res. 2017 May;37(5):2673-2677.

PMID:
28476843
16.

Hepatobiliary and Pancreatic: Hepatocellular carcinoma developed with angiomyolipoma.

Miyata T, Yamashita Y, Yamao T, Umezaki N, Tsukamoto M, Kitano Y, Yamamura K, Arima K, Kaida T, Nakagawa S, Imai K, Hashimoto D, Chikamoto A, Ishiko T, Asato T, Mikami Y, Aishima S, Baba H.

J Gastroenterol Hepatol. 2017 Mar;32(3):547. doi: 10.1111/jgh.13655. No abstract available.

PMID:
28320064
17.

Prognostic impacts of postoperative complications in patients with intrahepatic cholangiocarcinoma after curative operations.

Miyata T, Yamashita YI, Yamao T, Umezaki N, Tsukamoto M, Kitano Y, Yamamura K, Arima K, Kaida T, Nakagawa S, Imai K, Hashimoto D, Chikamoto A, Ishiko T, Baba H.

Int J Clin Oncol. 2017 Jun;22(3):526-532. doi: 10.1007/s10147-017-1099-9. Epub 2017 Feb 15.

PMID:
28205002
18.

Tarsal Tunnel Syndrome Due To Three Different Types of Ganglion During a 12-Year Period: A Case Report.

Kawakatsu M, Ishiko T, Sumiya M.

J Foot Ankle Surg. 2017 Mar - Apr;56(2):379-384. doi: 10.1053/j.jfas.2016.11.005. Epub 2017 Jan 7.

PMID:
28073652
19.

Preoperative platelet-to-lymphocyte ratio can predict recurrence beyond the Milan criteria after hepatectomy for patients with hepatocellular carcinoma.

Kaida T, Nitta H, Kitano Y, Yamamura K, Arima K, Higashi T, Taki K, Nakagawa S, Okabe H, Hayashi H, Imai K, Hashimoto D, Yamashita YI, Chikamoto A, Ishiko T, Beppu T, Baba H.

Hepatol Res. 2017 Sep;47(10):991-999. doi: 10.1111/hepr.12835. Epub 2016 Dec 21.

PMID:
28000365
20.

Shape and Enhancement Characteristics of Pancreatic Neuroendocrine Tumor on Preoperative Contrast-enhanced Computed Tomography May be Prognostic Indicators.

Okabe H, Hashimoto D, Chikamoto A, Yoshida M, Taki K, Arima K, Imai K, Tamura Y, Ikeda O, Ishiko T, Uchiyama H, Ikegami T, Harimoto N, Itoh S, Yamashita YI, Yoshizumi T, Beppu T, Yamashita Y, Baba H, Maehara Y.

Ann Surg Oncol. 2017 May;24(5):1399-1405. doi: 10.1245/s10434-016-5630-4. Epub 2016 Nov 28.

PMID:
27896509
21.

C5a receptor (CD88) promotes motility and invasiveness of gastric cancer by activating RhoA.

Kaida T, Nitta H, Kitano Y, Yamamura K, Arima K, Izumi D, Higashi T, Kurashige J, Imai K, Hayashi H, Iwatsuki M, Ishimoto T, Hashimoto D, Yamashita Y, Chikamoto A, Imanura T, Ishiko T, Beppu T, Baba H.

Oncotarget. 2016 Dec 20;7(51):84798-84809. doi: 10.18632/oncotarget.12656.

22.

Pre-treatment double- or triple-positive tumor markers are predictive of a poor outcome for patients undergoing radiofrequency ablation for hepatocellular carcinoma.

Nitta H, Nakagawa S, Kaida T, Arima K, Higashi T, Taki K, Okabe H, Hayashi H, Hashimoto D, Chikamoto A, Ishiko T, Beppu T, Baba H.

Surg Today. 2017 Mar;47(3):375-384. doi: 10.1007/s00595-016-1385-6. Epub 2016 Aug 22.

PMID:
27549776
23.

Anatomic Variations of the Flexor Carpi Radialis Brevis: A Report of Five Cases.

Nagata J, Kojima Y, Satomura K, Ishiko T, Ajiki T.

J Hand Surg Asian Pac Vol. 2016 Feb;21(1):113-5. doi: 10.1142/S2424835516720061.

PMID:
27454515
24.

A long survivor with local relapse of hilar cholangiocarcinoma after R1 surgery treated with chemoradiotherapy: a case report and literature review.

Okabe H, Chikamoto A, Maruno M, Hashimoto D, Imai K, Taki K, Arima K, Ishiko T, Uchiyama H, Ikegami T, Harimoto N, Itoh S, Yoshizumi T, Beppu T, Baba H, Maehara Y.

Surg Case Rep. 2016 Dec;2(1):69. doi: 10.1186/s40792-016-0195-9. Epub 2016 Jul 4.

25.

Inheritance of a Nuclear PIWI from Pluripotent Stem Cells by Somatic Descendants Ensures Differentiation by Silencing Transposons in Planarian.

Shibata N, Kashima M, Ishiko T, Nishimura O, Rouhana L, Misaki K, Yonemura S, Saito K, Siomi H, Siomi MC, Agata K.

Dev Cell. 2016 May 9;37(3):226-37. doi: 10.1016/j.devcel.2016.04.009.

26.

Diverse Basis of β-Catenin Activation in Human Hepatocellular Carcinoma: Implications in Biology and Prognosis.

Okabe H, Kinoshita H, Imai K, Nakagawa S, Higashi T, Arima K, Uchiyama H, Ikegami T, Harimoto N, Itoh S, Ishiko T, Yoshizumi T, Beppu T, Monga SP, Baba H, Maehara Y.

PLoS One. 2016 Apr 21;11(4):e0152695. doi: 10.1371/journal.pone.0152695. eCollection 2016.

27.

Successful treatment for sorafenib-induced liver dysfunction: a report of case with liver biopsy.

Kuroda D, Hayashi H, Nitta H, Imai K, Abe S, Hashimoto D, Chikamoto A, Ishiko T, Beppu T, Baba H.

Surg Case Rep. 2016 Dec;2(1):4. doi: 10.1186/s40792-016-0131-z. Epub 2016 Jan 14.

28.

Simultaneous Laparoscopic Resection of Primary Tumor and Liver Metastases for Colorectal Cancer: Surgical Technique and Short-Term Outcome.

Miyamoto Y, Beppu T, Sakamoto Y, Imai K, Hayashi H, Nitta H, Ishiko T, Watanabe M, Baba H.

Hepatogastroenterology. 2015 Jun;62(140):846-52.

PMID:
26902014
29.

Education and Imaging. Hepatobiliary and Pancreatic: Replaced common hepatic artery on left gastric artery: a rare anomaly and implication for pancreaticoduodenectomy.

Daitoku N, Okabe H, Hashimoto D, Chikamoto A, Hayashi H, Nitta H, Taki K, Higashi T, Kaida T, Arima K, Ishiko T, Beppu T, Baba H.

J Gastroenterol Hepatol. 2015 Dec;30(12):1695. doi: 10.1111/jgh.12968. No abstract available.

PMID:
26768946
30.

Inducible factors for cancer-associated fibroblasts in liver cancer versus myofibroblasts in inflammatory liver disease.

Okabe H, Hayashi H, Nakagawa S, Imai K, Nitta H, Arima K, Hashimoto D, Chikamoto A, Ishiko T, Beppu T, Baba H.

Histol Histopathol. 2016 Feb;31(2):141-8. doi: 10.14670/HH-11-668. Epub 2015 Sep 23. Review.

PMID:
26398776
31.

Repeated hepatic resections and radio-frequency ablations may improve the survival of adult undifferentiated embryonal sarcoma of the liver: report of two cases.

Masuda T, Beppu T, Doi K, Miyata T, Nakagawa S, Okabe H, Hayashi H, Ishiko T, Iyama K, Baba H.

Surg Case Rep. 2015;1(1):55. doi: 10.1186/s40792-015-0056-y. Epub 2015 Jun 27.

32.

Hepatic angiomyolipoma with special attention to radiologic imaging.

Kuramoto K, Beppu T, Namimoto T, Hayashi H, Imai K, Nitta H, Hashimoto D, Chikamoto A, Ishiko T, Iyama K, Ikeda O, Yamashita Y, Baba H.

Surg Case Rep. 2015;1(1):38. doi: 10.1186/s40792-015-0038-0. Epub 2015 Apr 24.

33.

Regeneration of elastic fibers by three-dimensional culture on a collagen scaffold and the addition of latent TGF-β binding protein 4 to improve elastic matrix deposition.

Aya R, Ishiko T, Noda K, Yamawaki S, Sakamoto Y, Tomihata K, Katayama Y, Yoshikawa K, Kubota H, Nakamura T, Naitoh M, Suzuki S.

Biomaterials. 2015 Dec;72:29-37. doi: 10.1016/j.biomaterials.2015.08.036. Epub 2015 Aug 20.

34.

Hepatobiliary and Pancreatic: Skin metastases from cholangiocarcinoma mimicking herpes zoster.

Okabe H, Hashimoto D, Chikamoto A, Hayashi H, Nitta H, Taki K, Higashi T, Arima K, Ishiko T, Beppu T, Baba H.

J Gastroenterol Hepatol. 2015 Sep;30(9):1337. doi: 10.1111/jgh.12964. No abstract available.

PMID:
26211694
35.

Significance of P-cadherin overexpression and possible mechanism of its regulation in intrahepatic cholangiocarcinoma and pancreatic cancer.

Sakamoto K, Imai K, Higashi T, Taki K, Nakagawa S, Okabe H, Nitta H, Hayashi H, Chikamoto A, Ishiko T, Beppu T, Baba H.

Cancer Sci. 2015 Sep;106(9):1153-62. doi: 10.1111/cas.12732. Epub 2015 Aug 18.

36.

Recurrence-free survival of a hepatocellular carcinoma patient with tumor thrombosis of the inferior vena cava after treatment with sorafenib and hepatic resection.

Nakamura K, Beppu T, Hayashi H, Okabe H, Imai K, Nitta H, Chikamoto A, Ishiko T, Sasaki M, Baba H.

Int Surg. 2015 May;100(5):908-14. doi: 10.9738/INTSURG-D-14-00133.1.

37.

Endoscopic radiofrequency ablation in elderly patients with hepatocellular carcinoma.

Doi K, Beppu T, Ishiko T, Chikamoto A, Hayashi H, Imai K, Nitta H, Baba Y, Masuda T, Okabe K, Kuramoto M, Kudo K, Ogata K, Ohchi T, Takamori H, Kikuchi K, Baba H.

Anticancer Res. 2015 May;35(5):3033-40.

PMID:
25964592
38.

Effect of branched-chain amino acid supplementation on functional liver regeneration in patients undergoing portal vein embolization and sequential hepatectomy: a randomized controlled trial.

Beppu T, Nitta H, Hayashi H, Imai K, Okabe H, Nakagawa S, Hashimoto D, Chikamoto A, Ishiko T, Yoshida M, Yamashita Y, Baba H.

J Gastroenterol. 2015 Dec;50(12):1197-205. doi: 10.1007/s00535-015-1067-y. Epub 2015 Apr 8.

PMID:
25847401
39.

Hybrid-including endoscopic versus open hepatic resection for patients with hepatocellular carcinoma meeting the Milan criteria: a propensity case-matched analysis.

Beppu T, Hayashi H, Okabe H, Imai K, Nitta H, Masuda T, Hashimoto D, Chikamoto A, Ishiko T, Kikuchi K, Baba H.

Anticancer Res. 2015 Mar;35(3):1583-90.

PMID:
25750314
40.

[Short-term adjuvant hepatic arterial infusion chemotherapy after hepatic resection for hepatocellular carcinoma with macrovascular invasion].

Takeyama H, Nitta H, Higashi T, Sakamoto K, Nakagawa S, Hayashi M, Imai K, Hashimoto D, Chikamoto A, Ishiko T, Beppu T, Baba H.

Gan To Kagaku Ryoho. 2014 Nov;41(12):1506-8. Japanese.

PMID:
25731234
41.

Functional assessment versus conventional volumetric assessment in the prediction of operative outcomes after major hepatectomy.

Hayashi H, Beppu T, Okabe H, Kuroki H, Nakagawa S, Imai K, Nitta H, Chikamoto A, Ishiko T, Baba H.

Surgery. 2015 Jan;157(1):20-6. doi: 10.1016/j.surg.2014.06.013.

PMID:
25482462
42.

A toe keloid after syndactyly release treated with surgical excision and intralesional steroid injection.

Yamawaki S, Naitoh M, Ishiko T, Aya R, Katayama Y, Suzuki S.

Plast Reconstr Surg Glob Open. 2014 Aug 7;2(7):e186. doi: 10.1097/GOX.0000000000000152. eCollection 2014 Jul.

43.

Poor outcomes after hepatectomy in patients with ascites infected by methicillin-resistant staphylococci.

Nitta H, Beppu T, Itoyama A, Higashi T, Sakamoto K, Nakagawa S, Mima K, Okabe H, Imai K, Hayashi H, Hashimoto D, Chikamoto A, Ishiko T, Baba H.

J Hepatobiliary Pancreat Sci. 2015 Feb;22(2):166-76. doi: 10.1002/jhbp.175. Epub 2014 Oct 22.

PMID:
25339191
44.

Gluten ataxia in Japan.

Nanri K, Mitoma H, Ihara M, Tanaka N, Taguchi T, Takeguchi M, Ishiko T, Mizusawa H.

Cerebellum. 2014 Oct;13(5):623-7. doi: 10.1007/s12311-014-0582-3.

PMID:
24997752
45.

Clinicopathological and prognostic significance of preoperative serum zinc status in patients with hepatocellular carcinoma after initial hepatectomy.

Imai K, Beppu T, Yamao T, Okabe H, Hayashi H, Nitta H, Hashimoto D, Mima K, Nakagawa S, Sakamoto K, Chikamoto A, Ishiko T, Baba H.

Ann Surg Oncol. 2014 Nov;21(12):3817-26. doi: 10.1245/s10434-014-3786-3. Epub 2014 May 20.

PMID:
24841354
46.

Immunoadsorption therapy for neuromyelitis optica spectrum disorders long after the acute phase.

Kobayashi M, Nanri K, Taguchi T, Ishiko T, Yoshida M, Yoshikawa N, Sugisaki K, Tanaka N.

J Clin Apher. 2015 Feb;30(1):43-5. doi: 10.1002/jca.21324. Epub 2014 May 6.

PMID:
24802352
47.

Percutaneous radiofrequency ablation-assisted laparoscopic hepatectomy.

Beppu T, Nitta H, Tsukamoto M, Imai K, Hayashi H, Okabe H, Hashimoto D, Chikamoto A, Ishiko T, Baba H.

Asian J Endosc Surg. 2014 May;7(2):188-92. doi: 10.1111/ases.12088.

PMID:
24754887
48.

Rank classification based on the combination of indocyanine green retention rate at 15 min and (99m)Tc-DTPA-galactosyl human serum albumin scintigraphy predicts the safety of hepatic resection.

Okabe H, Beppu T, Hayashi H, Mima K, Nakagawa S, Kuroki H, Imai K, Nitta H, Masuda T, Hashimoto D, Chikamoto A, Watanabe M, Ishiko T, Yoshida M, Yamashita Y, Baba H.

Nucl Med Commun. 2014 May;35(5):478-83. doi: 10.1097/MNM.0000000000000075.

PMID:
24686196
49.

CYLD downregulation is correlated with tumor development in patients with hepatocellular carcinoma.

Kinoshita H, Okabe H, Beppu T, Chikamoto A, Hayashi H, Imai K, Mima K, Nakagawa S, Yokoyama N, Ishiko T, Shinriki S, Jono H, Ando Y, Baba H.

Mol Clin Oncol. 2013 Mar;1(2):309-314. Epub 2013 Jan 14.

50.

Chemotherapy and targeted therapy for patients with initially unresectable colorectal liver metastases, focusing on conversion hepatectomy and long-term survival.

Beppu T, Miyamoto Y, Sakamoto Y, Imai K, Nitta H, Hayashi H, Chikamoto A, Watanabe M, Ishiko T, Baba H.

Ann Surg Oncol. 2014 Jun;21 Suppl 3:S405-13. doi: 10.1245/s10434-014-3577-x. Epub 2014 Feb 26.

PMID:
24570379

Supplemental Content

Loading ...
Support Center